Follow us on
SMS-oncology

Blog

AACR2018 - Emerging trends in next generation immunotherapy

AACR2018 - Emerging trends in next generation immunotherapy

25 April 2018, Nadina Grosios and Yuva Oz

Chicago hosted the 2018 annual meeting of the American Association for Cancer Research (AACR) in its cold spring days. As expected, enthusiasm centered on immunotherapy combination therapy and its challenges, and the possibilities offere...Read more

The future of data management in clinical trials - ACDM 2018

The future of data management in clinical trials - ACDM 2018

11 April 2018, José Matamoros Luna, Clinical Data Manager

On March 13, Brussels was considered the capital of Data Management, hosting the annual conference of the Association for Clinical Data Management (ACDM). Since technologies and standards continue to evolve in the ever changing landscape...Read more

Power of targeted, personalized and combined therapies - TAT 2018

Power of targeted, personalized and combined therapies - TAT 2018

9 March 2018, Yuva Oz, Business Developer

The home of Phase I oncology conference a.k.a. the Targeted Anticancer Therapies (TAT) conference took place this week in the beautiful city of Paris. The program is dedicated to early-phase development and translational research, and at...Read more

EMA anticancer drug recommendations for approval in 2017

EMA anticancer drug recommendations for approval in 2017

23 January 2018, Julia Holland, Consultant & Kun Shi, Consultant

In 2017, the European Medicines Agency (EMA) made a total of 92 positive recommendations to the European Commission for medicines to receive marketing approval. Approximately one fourth (23/92) were aimed at cancer treatment, which almos...Read more

No child should die of cancer: paediatric oncology trials in Europe and USA

No child should die of cancer: paediatric oncology trials in Europe and USA

12 December 2017, José Matamoros Luna, Clinical Data Manager

Paediatric oncology has in general been one of the most successful areas of oncology where current treatments can achieve good efficacy and long term survival. However, this is still not the case for a significant number of children suff...Read more

Are you ready for the new EudraVigilance System?

Are you ready for the new EudraVigilance System?

1 November 2017, Canan Karakaya, Pharmacovigilance Manager

The new system has implications for all users of the EudraVigilance system, such as National Competent Authorities, Marketing Authorisation Holders and Sponsors of clinical trials. All users have to ensure that their processes and local...Read more

CICON2017: Translating Science into Survival #3

CICON2017: Translating Science into Survival #3

20 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Fran...Read more

CICON2017: Translating Science into Survival #2

CICON2017: Translating Science into Survival #2

19 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Fran...Read more

CICON2017: Translating Science into Survival #1

CICON2017: Translating Science into Survival #1

15 September 2017, Julia Holland, PhD

Over the week we will publish a blog mini-series of each day's key highlights from the Third CRI-CIMT-EATI-AACR (CICON17) International Cancer Immunotherapy Conference: Translating Science into Survival (September 6-9, 2017 in Mainz/Fran...Read more

The year after; was the CRA-academy really the gateway to become a great CRA?

The year after; was the CRA-academy really the gateway to become a great CRA?

22 June 2017, Alicia Veerman MSc, Clinical Research Associate

So here we are again, already more than a year later since we participated in SMS-oncology's first CRA-academy. Might sound cliché but time indeed seems to fly when you are having fun. We certainly enjoyed the past year, and more importa...Read more

Compassionate Use: providing cancer care outside trials

Compassionate Use: providing cancer care outside trials

2 May 2017, Fleur Eeman MSc, Clinical Research Associate & Jasmijn Hubers MD PhD, Medical Monitor

Being a challenging and arduous operation, finding new therapies to treat cancer often is a time-consuming process. For some patients, marketed therapies are to no avail, while at the same moment new optional therapies are on the way to...Read more

Archive
Request for proposal
Subscribe to our oncology feed
Contact us